List of pharmaceutical compound number prefix

From Wikipedia, the free encyclopedia

 This article is orphaned as few or no other articles link to it.
Please help introduce links in articles on related topics. (December 2007)
This article does not cite any references or sources. (September 2007)
Please help improve this article by adding citations to reliable sources. Unverifiable material may be challenged and removed.

This list of pharmaceutical compound number prefixes details a drug labeling standard. Pharmaceutical companies produce a large number of compounds. The compounds are systematically numbered, such as CP-529414 (for the recently failed Pfizer experimental drug torcetrapib). In addition to the number, there are several letters (the "prefix") that usually tells which company the compound comes from. Since the pharmaceutical industry has gone through a lot of mergers and acquisitions, the original company and the current company are both listed.

Contents

[edit] A to F

  • ABT - Abbott Labs
  • ACP - Acadia Phamarceuticals
  • ADL - Adolor Corporation [1]
  • AG - Agouron, now Pfizer La Jolla Labs
    • Example: AG-013736, or Axitinib, an experimental cancer drug
  • AGI - AtheroGenics
  • ALS - Alantos Pharmaceuticals, acquired by Amgen in June 2007
    • Example: ALS 2-0426, an experimental drug for diabetes
  • ANX - Adventrx Pharmaceuticals [2]
  • AMG - Amgen
  • ARQ - ArQule
  • ATL - Antisense Therapeutics Limited, Australia [3]
  • AZD - AstraZeneca
  • BMS - Bristol-Myers Squibb
    • Example: BMS-562247 or apixaban, an experimental anti-coagulant drug targeting Factor Xa
  • BRL - Beecham Research Labs, merged with SmithKline into SmithKline Beecham which merged into GlaxoSmithKline
  • CAT - Cannasat Therapeutics Inc.
  • CE - Pfizer
  • CGS - Ciba Geige
  • CP - Pfizer Groton. CP probably refer to the founder of the company, Charles Pfizer
    • Example: CP-751871, an experimental cancer drug for non-adenocarcinoma
  • CSL - CSL Ltd, an Australian Biophamaceutical company
  • DMP - DuPont Merck Pharmaceuticals, a joint venture between DuPont and Merck, turns to DuPont Pharmaceuticals in 1998
  • DPC - DuPont Pharmaceuticals, acquired by Bristol-Myers Squibb in 2001
    • Example: DPC-906, or razaxaban, an experimental anti-coagulant drug targeting Factor Xa
  • ETC - Esperion Therapeutics, acquired by Pfizer in 2003

[edit] G to L

[edit] M to S

[edit] T to Z

  • TAK - Takeda
    • Example: TAK-491, an experimental drug for hypertension
  • TC - Targacept Inc.
  • TG - Tragara Pharmaceuticals Inc. San Diego, CA
  • TM - TransMolecular, Inc. [4]
    • Example: TMC125, experimental HIV drug targeting NNRTI
  • TMC - Tibotec Pharmaceuticals
  • TNP - Takeda Neosplastic Product, from Takeda Pharmaceutical Company, Japan
    • Example: TNP-470, an antiangiogenesis agent, analog of fumagilin
  • TS - Taisho Pharmaceutical Co., a Japanese Pharmaceutical Company [5]
  • UK - Pfizer Sandwich, UK
  • VX - Vertex Pharmaceuticals
  • XL - Exelexis
  • XTL - XTL Biopharmaceuticals
    • Example: XTL-2125, an experimental drug for hepatitis C, failed in phase I in June 2007

[edit] References

  1. ^ ADL5747. Retrieved on 2008-03-19.
  2. ^ Adventrx Product List. Retrieved on 2007-11-18.
  3. ^ Antisense Therapeutics Ltd Home Page. Retrieved on 2008-02-20.
  4. ^ TransMolecular Product Pipeline. Retrieved on 2007-11-18.
  5. ^ Taisho Press Release. Retrieved on 2008-01-07.